Perampanel (Hydrate)
Perampanel (Hydrate) is a non-competitive AMPA glutamate receptor antagonist used as adjunctive therapy for partial-onset seizures.
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Perampanel (Hydrate) – CAS 1571982-04-1
CAS Number
1571982-04-1
Category
Anti-convulsant
Therapeutic Class
AMPA receptor antagonist
Description
Perampanel (Hydrate) is a non-competitive AMPA glutamate receptor antagonist used as adjunctive therapy for partial-onset seizures.
Applications
- Partial-onset seizures
- Primary generalized tonic-clonic seizures
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.